Grufity logoGrufity logo
StocksFundsSearch Filings

Allscripts Healthcare Solutions Inc Stock Research

MDRX

11.90USD+0.01(+0.08%)Market Closed

Market Summary

USD11.90+0.01
Market Closed
0.08%

MDRX Stock Price

MDRX RSI Chart

MDRX Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

22.47

Price/Sales (Trailing)

1.63

EV/EBITDA

2.9

Price/Free Cashflow

8.81

MDRX Price/Sales (Trailing)

MDRX Profitability

Operating Margin

-4.40%

EBT Margin

14.59%

Return on Equity

5.15%

Return on Assets

3.59%

Free Cashflow Yield

11.35%

MDRX Fundamentals

MDRX Revenue

Revenue (TTM)

837.2M

Revenue Y/Y

5.01%

Revenue Q/Q

0.68%

MDRX Earnings

Earnings (TTM)

60.6M

Earnings Y/Y

-10.21%

Earnings Q/Q

122.69%

Price Action

52 Week Range

11.5719.77
(Low)(High)

Last 7 days

-1.6%

Last 30 days

-3.2%

Last 90 days

-29.4%

Trailing 12 Months

-29.9%

MDRX Financial Health

Current Ratio

3.2

Debt/Equity

0.02

Debt/Cashflow

7.14

MDRX Investor Care

Buy Backs (1Y)

10.86%

Diluted EPS (TTM)

0.39

Peers (Alternatives to Allscripts Healthcare Solutions)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
448.8B
335.9B
-0.30% -2.84%
21.68
1.34
12.90% 18.65%
26.0B
2.2B
-6.51% -0.02%
53.24
12.05
16.44% 14.11%
MID-CAP
9.0B
-
11.88% 31.28%
-116.8
2.57
- -
3.7B
2.5B
-11.99% -32.20%
-0.53
1.5
15.22% -2.18%
3.3B
1.3B
24.63% -32.85%
583.74
2.54
14.48% -92.74%
SMALL-CAP
1.6B
280.9M
-4.19% 67.00%
-9.15
5.74
31.74% -49.07%
1.4B
837.2M
-3.25% -29.92%
22.47
1.63
3.88% -92.18%
1.0B
653.2M
-10.02% -15.43%
-381.88
1.55
9.53% -264.03%
920.4M
2.6B
15.69% 53.16%
5.9
0.35
23.61% -10.67%
897.5M
54.4M
8.85% -3.12%
85.74
16.5
9.18% -9.20%
717.7M
270.4M
-7.09% 16.48%
60.71
2.65
4.56% 83.36%
616.5M
282.0M
-8.00% -22.47%
-4.16
2.19
10.96% -0.57%
364.2M
335.0M
-6.83% -22.50%
33.6
1.09
15.32% -51.61%

Financials for Allscripts Healthcare Solutions

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue0.9%837830820811806
Cost Of Revenue-0.7%874881882883444
Gross Profit2.2%655641630620362
  S&GA Expenses1.4%360355323314181
  R&D Expenses1.3%201198196194117
EBITDA-0.4%300301164202-
EBITDA Margin-1.2%0.36*0.36*0.16*0.16*-
Earnings Before Taxes-2.1%122125160162-11.57
EBT Margin2.1%0.15*0.14*0.15*0.13*-
Interest Expenses-21.4%9.0011.0012.0013.0016.00
Net Income-2.7%61.0062.00148134775
Net Income Margin-3.5%0.07*0.08*0.14*0.11*-
Free Cahsflow-14.9%155182-16.16-80.72-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-1.4%1,6911,7142,4302,4252,484
  Current Assets-2.2%8118291,541761805
    Cash Equivalents-1.5%49350083.00133142
  Net PPE-21.8%12.0015.009.0010.0054.00
  Goodwill0.0%524524520507974
Liabilities-0.8%5145181,0771,0171,066
  Current Liabilities-1.3%253256647547567
  Long Term Debt-26.00----
    LT Debt, Non Current0.2%200200377350373
Shareholder's Equity-1.6%1,1771,1961,3531,4081,419
  Retained Earnings2.0%75373980313.00680
  Additional Paid-In Capital0.0%1,9241,9241,9221,9621,952
Accumulated Depreciation-323----
Shares Outstanding-1.4%109111115116123
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-14.7%161189-10.74-75.43-319
  Share Based Compensation1.2%46.0046.0039.0035.0017.00
Cashflow From Investing1.7%646635-37.38-12.171,625
Cashflow From Financing2.2%-520-532-314-258-1,315
  Buy Backs13.4%286252467417589

Risks for MDRX

What is the probability of a big loss on MDRX?

91.5%


Probability that Allscripts Healthcare Solutions stock will be more than 20% underwater in next one year

58.1%


Probability that Allscripts Healthcare Solutions stock will be more than 30% underwater in next one year.

21.9%


Probability that Allscripts Healthcare Solutions stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MDRX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Allscripts Healthcare Solutions was unfortunately bought at previous high price.

Drawdowns

Returns for MDRX

Cumulative Returns on MDRX

-1.5%


10-Year Cumulative Returns

-1.6%


7-Year Cumulative Returns

-1.3%


5-Year Cumulative Returns

21.0%


3-Year Cumulative Returns

What are the long-term rolling returns for MDRX?

FIve years rolling returns for Allscripts Healthcare Solutions.

Annualized Returns

Which funds bought or sold MDRX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-05-23
ROYCE & ASSOCIATES LP
added
144
528,466
1,180,230
0.01%
2023-05-23
Brookfield Corp /ON/
reduced
-36.77
-514,359
452,013
-%
2023-05-23
Front Row Advisors LLC
unchanged
-
-1,000
3,000
-%
2023-05-22
PUTNAM INVESTMENTS LLC
added
456
6,637,200
8,767,670
0.01%
2023-05-22
AMERIPRISE FINANCIAL INC
added
15.19
-1,469,470
8,464,530
-%
2023-05-18
JPMORGAN CHASE & CO
reduced
-43.55
-18,527,100
13,285,900
-%
2023-05-18
NEW YORK STATE COMMON RETIREMENT FUND
reduced
-32.51
-975,000
973,000
-%
2023-05-17
Advisory Services Network, LLC
unchanged
-
-1,606
4,568
-%
2023-05-17
Thrivent Financial for Lutherans
reduced
-3.39
-564,000
1,413,000
-%
2023-05-17
VIRGINIA RETIREMENT SYSTEMS ET AL
added
110
1,119,570
1,896,300
0.02%

1–10 of 42

Latest Funds Activity

Are funds buying MDRX calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own MDRX
No. of Funds

Allscripts Healthcare Solutions News

Business Insider
BoFA: Buy These 30 Small-Cap Stocks Set to Outperform Amidst ....
Business Insider,
2 months ago
Business Insider
Yahoo Finance
Business Wire
ETF Daily News
Behavioral Health Business
Business Wire
Yahoo Finance
The Motley Fool Canada
Why I Own Constellation Software Stock.
The Motley Fool Canada,
7 months ago

Schedule 13G FIlings of Allscripts Healthcare Solutions

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 10, 2023
dimensional fund advisors lp
8.5%
9,277,320
SC 13G/A
Feb 09, 2023
vanguard group inc
12.40%
13,550,569
SC 13G/A
Jan 26, 2023
blackrock inc.
19.1%
20,902,942
SC 13G/A
Jan 20, 2023
blackrock inc.
19.1%
20,902,942
SC 13G/A
Feb 09, 2022
vanguard group inc
10.82%
13,268,135
SC 13G/A
Feb 08, 2022
dimensional fund advisors lp
8.2%
10,090,569
SC 13G/A
Jan 28, 2022
blackrock inc.
19.5%
23,846,502
SC 13G/A
Apr 12, 2021
wellington management group llp
3.78%
5,292,953
SC 13G/A
Feb 12, 2021
dimensional fund advisors lp
6.9%
10,939,535
SC 13G/A
Feb 10, 2021
vanguard group inc
10.11%
15,973,325
SC 13G/A

MDRX Fair Value

Allscripts Healthcare Solutions fair value in different scenarios

The table shows the Fair Value estimates for Allscripts Healthcare Solutions for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

4.48

-62.35%

5.11

-57.06%

6.43

-45.97%

7.64

-35.80%

9.54

-19.83%
Current Inflation

4.40

-63.03%

5.00

-57.98%

6.20

-47.90%

7.30

-38.66%

8.82

-25.88%
Very High Inflation

4.31

-63.78%

4.85

-59.24%

5.91

-50.34%

6.87

-42.27%

7.96

-33.11%

Historical Allscripts Healthcare Solutions Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Allscripts Healthcare Solutions

View All Filings
Date Filed Form Type Document
May 26, 2023
4
Insider Trading
May 19, 2023
8-K
Current Report
May 11, 2023
4
Insider Trading
May 11, 2023
4
Insider Trading
May 11, 2023
4
Insider Trading
May 11, 2023
NT 10-Q
NT 10-Q
May 03, 2023
4
Insider Trading
May 03, 2023
4
Insider Trading
May 03, 2023
4
Insider Trading
Apr 03, 2023
4
Insider Trading

Latest Insider Trading transactions for MDRX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-05-10
Poulton Richard J.
sold (taxes)
-157,140
11.9
-13,205
ceo
2023-05-10
Vakharia Tejal
sold (taxes)
-37,711
11.9
-3,169
svp general counsel
2023-05-10
Hammond Lisa
sold (taxes)
-28,000
11.9
-2,353
svp & chief hr officer
2023-05-02
Langan Thomas
sold (taxes)
-22,999
12.15
-1,893
president and cco
2023-05-02
Jones Leah
sold (taxes)
-27,009
12.15
-2,223
chief financial officer
2023-05-01
Vakharia Tejal
sold (taxes)
-53,891
12.53
-4,301
svp general counsel
2023-05-01
Jones Leah
sold (taxes)
-86,031
12.53
-6,866
chief financial officer
2023-05-01
Langan Thomas
sold (taxes)
-117,206
12.53
-9,354
president and cco
2023-04-01
Vakharia Tejal
sold (taxes)
-33,447
13.05
-2,563
svp general counsel
2023-04-01
Langan Thomas
sold (taxes)
-193,218
13.05
-14,806
president and cco

1–10 of 50

Richard J. Poulton
8000
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

MDRX Income Statement

2022-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:    
Revenue from contract with customers$ 151,922$ 144,668$ 445,492$ 419,526
Cost of revenue:    
Total cost of revenue68,48675,028209,093218,550
Gross profit83,43669,640236,399200,976
Selling, general and administrative expenses32,51827,392133,68387,680
Research and development23,68121,04269,85162,644
Asset impairment charges03590531
Amortization of intangible and acquisition-related assets2,2362,3636,6487,090
Income from operations25,00118,48426,21743,031
Interest expense(1,246)(3,617)(5,269)(9,709)
Other income, net1,6554,4933,80021,819
Gain on sale of businesses, net08,36308,363
Equity in net loss income of unconsolidated investments(617)(257)(1,222)(321)
Income from continuing operations before income taxes24,79327,46623,52663,183
Income tax (provision) benefit(13,868)(7,190)9,132(12,464)
Income from continuing operations, net of tax10,92520,27632,65850,719
Income (loss) from discontinued operations(434)(6,187)(9,252)(6,545)
Gain on sale of discontinued operations5,17407,939647
Income tax effect on discontinued operations(1,137)2,091(57,986)2,342
Income (loss) from discontinued operations, net of tax3,603(4,096)(59,299)(3,556)
Net income (loss)$ 14,528$ 16,180$ (26,641)$ 47,163
Basic    
Continuing operations$ 0.10$ 0.16$ 0.29$ 0.38
Discontinued operations0.03(0.03)(0.52)(0.03)
Net earnings (loss) per Common Share0.130.13(0.23)0.35
Diluted    
Continuing operations0.090.150.250.36
Discontinued operations0.03(0.03)(0.44)(0.03)
Net earnings (loss) per Common Share$ 0.12$ 0.12$ (0.19)$ 0.33
Provider [Member]    
Revenue:    
Revenue from contract with customers$ 122,811$ 118,179$ 360,415$ 345,253
Cost of revenue:    
Total cost of revenue57,25261,606172,595180,566
Payer & Life Sciences [Member]    
Revenue:    
Revenue from contract with customers29,11126,48985,07774,273
Cost of revenue:    
Total cost of revenue$ 11,234$ 13,422$ 36,498$ 37,984

MDRX Balance Sheet

2022-09-30
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 492,597$ 132,517
Restricted cash1,3071,308
Accounts receivable, net of allowance of $12,868 and $13,360 as of September 30, 2022 and December 31, 2021, respectively169,029171,622
Contract assets, net of allowance of $564 and $576 as of September 30, 2022 and December 31, 2021, respectively65,45363,429
Prepaid expenses and other current assets74,38460,511
Assets held for sale8,000331,955
Total current assets attributable to discontinued operations810,770761,342
Fixed assets, net11,7139,819
Software development costs, net78,10374,688
Intangible assets, net145,255149,690
Goodwill523,927506,607
Deferred taxes, net60
Contract assets - long-term, net of allowance of $1,201 and $1,534 as of September 30, 2022 and December 31, 2021, respectively27,95728,174
Right-of-use assets - operating leases14,52018,324
Other assets78,40883,429
Long-term assets attributable to discontinued operations0793,156
Total assets1,690,6592,425,229
Current liabilities:  
Accounts payable12,6095,281
Accrued expenses82,91754,518
Accrued compensation and benefits33,85731,055
Deferred revenue98,930120,748
Current operating lease liabilities6,1666,133
Current liabilities attributable to discontinued operations18,612329,347
Total current liabilities attributable to discontinued operations253,091547,082
Long-term debt200,326350,062
Deferred revenue3,0601,839
Deferred taxes, net8,08216,625
Long-term operating lease liabilities12,31516,754
Other liabilities36,76233,823
Long-term liabilities attributable to discontinued operations050,906
Total liabilities513,6361,017,091
Commitments and contingencies
Stockholders’ equity:  
Preferred stock: $0.01 par value, 1,000 shares authorized, no shares issued and outstanding as of September 30, 2022 and December 31, 202100
Common stock: $0.01 par value, 349,000 shares authorized as of September 30, 2022 and December 31, 2021; 279,600 and 109,260 shares issued and outstanding as of September 30, 2022, respectively; 276,705 and 116,114 shares issued and outstanding as of December 31, 2021, respectively2,7942,766
Treasury stock: at cost, 170,340 and 160,591 shares as of September 30, 2022 and December 31, 2021, respectively(1,498,836)(1,321,805)
Additional paid-in capital1,923,5591,962,386
Retained earnings753,392767,556
Accumulated other comprehensive loss(3,886)(2,765)
Total stockholders’ equity1,177,0231,408,138
Total liabilities and stockholders’ equity$ 1,690,659$ 2,425,229